Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: Results from a randomised, controlled trial

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 10, 2013, Pages 1113-1118

  Weintraub, Daniel ^a,b   Duda, John E ^a,b   Carlson, Kimberly ^c   Luo, Ping ^c   Sagher, Oren ^d   Stern, Matthew ^a,b   Follett, Kenneth A ^e   Reda, Domenic ^c   Weaver, Frances M ^c,f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HINES VA HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; LEVODOPA;

ARTICLE; CONTROLLED STUDY; DEPRESSION; GLOBUS PALLIDUS INTERNA DEEP BRAIN STIMULATION SURGERY; HUMAN; MAJOR CLINICAL STUDY; NEUROSURGERY; PARKINSON DISEASE; PARKINSON DISEASE QUESTIONNAIRE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION SURGERY; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SYMPTOM; UNIFIED PARKINSON DISEASE RATING SCALE;

EID: 84884588026     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-304396     Document Type: Article

References (30)

1. Olanow CW, Stern MB, Sethi K. The scientific and clinical basis of the treatment of Parkinson disease (2009). Neurology 2009; 72 (Supplement 4):S1-S136.
2. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010; 362: 2077-91.
3. Weaver FM, Follett KA, Stern MB, et al. Randomized trial for deep brain stimulation for Parkinson's disease: 36 month outcomes. Neurology 2012; 79: 55-65.
4. Weintraub D, Burn DJ. Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord 2011; 26: 1022-31.
5. Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry 1999; 56: 617-26. (Pubitemid 29315633)
6. Stenager EN, Wermuth L, Stenager E, et al. Suicide in patients with Parkinson's disease: an epidemiological study. Acta Psychiatr Scand 1994; 90: 70-2. (Pubitemid 24212177)
7. Myslobodsky M, Lalonde FM, HIcks L. Are patients with Parkinson's disease suicidal? J Geriatr Psychiatry Neurol 2001; 14: 120-4. (Pubitemid 32830413)
8. Sher L, Oquendo MA, Mann JJ. Risk of suicide in mood disorders. Clinical Neuroscience Research 2011; 1: 337-44.
9. Hirschfeld RMA, Russell JM. Assessment and treatment of suicidal patients. N Engl J Med 1997; 337: 910-15. (Pubitemid 27408574)
10. Nazem S, Siderowf AD, Duda JE, et al. Suicidal and death ideation in Parkinson's disease. Mov Disord 2008; 10: 1573-9. PMCID: PMD18618660.
11. Burkhard PR, Vingerhoets FJG, Berney A, et al. Suicide after successful deep brain stimulation for movement disorders. Neurology 2004; 63: 2170-2. (Pubitemid 39636276)
12. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 13: 1925-34. (Pubitemid 37409709)
13. Funkiewiez A, Ardouin C, Caputo e, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 834-9. (Pubitemid 38658504)
14. Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008; 131: 2720-8.
15. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized clinical trial. JAMA 2009; 301: 63-73.
16. Beck AT, Steer RA, Brown GK. Manual for Beck Depression Inventory (BDI-II). San Antonio, TX: The Psychological Corporation, 1996.
17. Levin BE, Llabre MM, Weiner WJ. Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory. J Neurol Neurosurg Psychiatry 1988; 51: 1401-4. (Pubitemid 18262963)
18. Schrag A, Barone P, Brown RG, et al. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2007; 22: 1077-92. PMCID: PMC17394234. (Pubitemid 47067217)
19. Fahn S, Elton RL, the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, editors. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Health Care Information, 1987: 153-63.
20. Jenkinson C, Peto V, Fitzpatrick R, et al. Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the Short-form Health Survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39). Age Ageing 1995; 24: 505-9.
21. Ware JE, Sherbourne CD. The MOS 36 Item Short Form Health Survey (SF-36). 1. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
22. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896-908. (Pubitemid 44315982)
23. Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURB trial): a randomised, open-label trial. Lancet Neurol 2010; 9: 581-91.
24. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients. Arch Neurol 2010; 67: 589-95.
25. Lhommée E, Klinger H, Thobois S, et al. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviors. Brain 2012; 135: 1463-77.
26. Hirsch JK, Duberstein PR, Unutzer J. Chronic medical problems and distressful throughts of suicide in primary care patients: mitigating role of happiness. Int J Geriatr Psychiatry 2009; 24: 671-9.
27. Overholser JC, Braden A, Dieter L. Understanding suicide risk: identification of high-risk groups during high-risk times. J Clin Psychol 2012; 68: 334-48.
28. Soulas T, Gurruchage J-M, Palfi S, et al. Attempted and completed suicides after subthalamic nucleus stimulation for Parkinsons's disease. J Neurol Neurosurg Psychiatry 2008; 79: 952-4.
29. Albanese A, Piacentini S, Romito LMA, et al. Suicide after successful deep brain stimulation for movement disorders. Neurology 2005; 65: 499-500. (Pubitemid 41099830)
30. Temel Y, Tan S, Visser-Vandewalle V, et al. Parkinson's disease, DBS and suicide: a role for serotonin? Brain 2009; 132:e126 [Letter to the Editor].